Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis (Q38880884)
Jump to navigation
Jump to search
scientific article published on 29 April 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis |
scientific article published on 29 April 2015 |
Statements
1 reference
Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis (English)
1 reference
Stephan Philipp
1 reference
Justyna Sosna
1 reference
Johannes Plenge
1 reference
Holger Kalthoff
1 reference
1 reference
29 April 2015
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference